🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
The overall purpose of this study is to evaluate how effective Thromboelast...
Status
Completed
Location
The University of Texas Medical School at Houston
Start Date
2009-11
Trial ID
NCT02494726
Treatments Being Tested
The LAMBDA 002 registry study is an observational, longitudinal, multi-cent...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2022-11-04
Trial ID
NCT05170425
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
A prospective, mono-center, interventional study evaluating the effect of o...
Status
Completed
Location
CHU Rennes
Start Date
2019-06-11
Trial ID
NCT03942432
Treatments Being Tested
Diabetes mellitus is one of the most common metabolic disorders complicatin...
Status
Completed
Location
Department and Clinic of Neonatology, Jan Mikulicz-Radecki University Teaching Hospital, Wroclaw Medical University
Start Date
2019-12-13
Trial ID
NCT04937348
This is an interventional, prospective, single-center study designed to col...
Status
Not Yet Recruiting
Location
Institut Universitaire du Cancer Toulouse - Oncopole, Laboratoire d'oncogénétique
Start Date
2026-10-15
Trial ID
NCT07558343
Treatments Being Tested
Systemic sclerosis (SSc) is the most severe of the systemic autoimmune dise...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT04986514
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615